C07C309/18

Protein tyrosine phosphatases or SHP2 inhibitors and uses thereof

Small molecule compounds derived from -sulfophenylacetic amide (SPAA) are provided as novel sulfonic acid based pTyr mimetics. These compounds effectively inhibit a variety of protein tyrosine phosphatases (PTPs), such as mPTPA, mPTPB, LMWPTP, and Laforin. Use of these compounds as pharmaceutical agents for treating diseases associated with abnormal protein tyrosine phosphatase activity is also provided.

Protein tyrosine phosphatases or SHP2 inhibitors and uses thereof

Small molecule compounds derived from -sulfophenylacetic amide (SPAA) are provided as novel sulfonic acid based pTyr mimetics. These compounds effectively inhibit a variety of protein tyrosine phosphatases (PTPs), such as mPTPA, mPTPB, LMWPTP, and Laforin. Use of these compounds as pharmaceutical agents for treating diseases associated with abnormal protein tyrosine phosphatase activity is also provided.

FLUOROUS COMPOUND, METHOD OF PREPARING FLUOROUS TAGGED PROTEIN, AND METHOD OF IMMOBILIZING PROTEIN
20180356415 · 2018-12-13 · ·

A fluorous compound, a method of preparing a fluorous tagged protein, and a method of immobilizing protein are provided. The fluorous compound is represented by Y-L-R, wherein Y is a fluorous group; L is a linker, and the linker includes a bivalent group having a sulfo group, a bivalent group having a carboxyl group, or a bivalent group of hydrophilic amino acid; and R is a functional group capable of bonding to protein.

DAMPING-IMPARTING AGENT AND RESIN COMPOSITION FOR DAMPING MATERIAL
20180355193 · 2018-12-13 ·

The present invention aims to provide a coating material which has high mechanical stability and is capable of providing a coat which has excellent appearance and exhibits excellent damping properties in a wide temperature range. The present invention relates to a damping-imparting agent including a compound having a sulfosuccinic acid (salt) structure. The present invention also relates to a resin composition for damping materials, including an emulsion prepared by polymerizing a monomer component, the composition further including a component having a sulfosuccinic acid (salt) structure.

DAMPING-IMPARTING AGENT AND RESIN COMPOSITION FOR DAMPING MATERIAL
20180355193 · 2018-12-13 ·

The present invention aims to provide a coating material which has high mechanical stability and is capable of providing a coat which has excellent appearance and exhibits excellent damping properties in a wide temperature range. The present invention relates to a damping-imparting agent including a compound having a sulfosuccinic acid (salt) structure. The present invention also relates to a resin composition for damping materials, including an emulsion prepared by polymerizing a monomer component, the composition further including a component having a sulfosuccinic acid (salt) structure.

SMALL MOLECULE INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES AND USED THEREOF
20180170861 · 2018-06-21 ·

Small molecule compounds derived from -sulfophenylacetic amide (SPAA) are provided as novel sulfonic acid based pTyr mimetics. These compounds effectively inhibit a variety of protein tyrosine phosphatases (PTPs), such as mPTPA, mPTPB, LMWPTP, and Laforin. Use of these compounds as pharmaceutical agents for treating diseases associated with abnormal protein tyrosine phosphatase activity is also provided.

PROTEIN TYROSINE PHOSPHATASES OR SHP2 INHIBITORS AND USES THEREOF
20180170862 · 2018-06-21 ·

Small molecule compounds derived from -sulfophenylacetic amide (SPAA) are provided as novel sulfonic acid based pTyr mimetics. These compounds effectively inhibit a variety of protein tyrosine phosphatases (PTPs), such as mPTPA, mPTPB, LMWPTP, and Laforin. Use of these compounds as pharmaceutical agents for treating diseases associated with abnormal protein tyrosine phosphatase activity is also provided.

PROTEIN TYROSINE PHOSPHATASES OR SHP2 INHIBITORS AND USES THEREOF
20180170862 · 2018-06-21 ·

Small molecule compounds derived from -sulfophenylacetic amide (SPAA) are provided as novel sulfonic acid based pTyr mimetics. These compounds effectively inhibit a variety of protein tyrosine phosphatases (PTPs), such as mPTPA, mPTPB, LMWPTP, and Laforin. Use of these compounds as pharmaceutical agents for treating diseases associated with abnormal protein tyrosine phosphatase activity is also provided.

Implantable material grafted with a cell antiproliferative and/or antibacterial film synthetized from a bifunctional molecule

The present invention relates to an implantable material having at least one external surface grafted with a film including carboxylate and sulfonate functions wherein the film is simultaneously synthesized and grafted directly on the external surface by radical reaction of a bifunctional adhesion primer of Formula (I) or by radical reaction of an adhesion primer and a bifunctional polymerizable monomer of Formula (II). ##STR00001## The invention also relates to a process for directly synthesizing and grafting of a film according to the invention onto at least one external surface of an implantable material. The invention further relates to the use of a grafted implantable material for the manufacture of an antiproliferative and/or antibacterial implantable medical device. The invention also relates to compounds of Formula (I) and Formula (II).

Implantable material grafted with a cell antiproliferative and/or antibacterial film synthetized from a bifunctional molecule

The present invention relates to an implantable material having at least one external surface grafted with a film including carboxylate and sulfonate functions wherein the film is simultaneously synthesized and grafted directly on the external surface by radical reaction of a bifunctional adhesion primer of Formula (I) or by radical reaction of an adhesion primer and a bifunctional polymerizable monomer of Formula (II). ##STR00001## The invention also relates to a process for directly synthesizing and grafting of a film according to the invention onto at least one external surface of an implantable material. The invention further relates to the use of a grafted implantable material for the manufacture of an antiproliferative and/or antibacterial implantable medical device. The invention also relates to compounds of Formula (I) and Formula (II).